切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2024, Vol. 20 ›› Issue (05) : 511 -518. doi: 10.3877/cma.j.issn.1673-5250.2024.05.006

产科前沿专辑

产科弥散性血管内凝血及其评分系统的研究现状
刘子洋1, 崔俭俭1, 赵茵1,,2   
  1. 1.华中科技大学同济医学院附属协和医院妇产科,武汉 430022
    2.深圳华中科技大学研究院,深圳 518000
  • 收稿日期:2024-08-26 修回日期:2024-09-16 出版日期:2024-10-01
  • 通信作者: 赵茵
  • 基金资助:
    国家自然科学基金项目(82171678)深圳市自然科学基金项目(JCYJ20200109140614667)深圳市自然科学基金面上项目(JCYJ20230807143504009)

Current research status on obstetric disseminated intravascular coagulation and its scoring system

Ziyang Liu1, Jianjian Cui1, Yin Zhao1,,2   

  1. 1.Department of Obstetrics and Gynecology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,Hubei Province,China
    2.Research Institute of Huazhong University of Science and Technology in Shenzhen,Shenzhen 518000,Guangdong Province,China
  • Received:2024-08-26 Revised:2024-09-16 Published:2024-10-01
  • Corresponding author: Yin Zhao
引用本文:

刘子洋, 崔俭俭, 赵茵. 产科弥散性血管内凝血及其评分系统的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 511-518.

Ziyang Liu, Jianjian Cui, Yin Zhao. Current research status on obstetric disseminated intravascular coagulation and its scoring system[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 511-518.

产科弥散性血管内凝血(DIC)是产科严重并发症之一,具有临床表现多样、疾病进展快速、凝血功能异常复杂等特点,极大增加了早期诊断和治疗难度。临床对产科DIC 的诊断,主要依据患者基础疾病与特征性临床表现及实验室检查结果等进行综合判断,早期识别和正确干预是该病患者良好预后的关键。产科DIC评分系统具有便捷、精准、直观、可定量等优点,在产科DIC 临床诊断中发挥重要作用。目前国内外有不同的产科DIC评分系统。笔者拟就产科DIC 定义、孕妇发病率及不良结局,孕期生理性高凝状态,产科DIC发病机制及病理特点与孕妇临床表现及实验室检查指标,以及产科DIC诊断标准及评分系统演变的最新研究现状进行系统阐述,旨在为产科DIC 的临床诊治提供参考。

Disseminated intravascular coagulation(DIC)in obstetrics is one of the serious complications,characterized by diverse clinical manifestations,rapid disease progression,and complex of coagulation dysfunction,which greatly increase the difficulty of early diagnosis and treatment of pregnant women with DIC.The diagnosis of obstetrics DIC is mainly relied on a comprehensive assessment of the underlying diseases,characteristic clinical manifestations,and laboratory test results,while the key to a good prognosis of obstetrics DIC pregnant women lies on early identification and appropriate intervention.DIC scoring system in obstetrics came into being as a convenient,accurate,intuitive and quantifiable diagnostic method.At present,there are different obstetric DIC scoring systems both domestically and internationally.The author intends to systematically elaborate the definition of obstetric DIC,incidence and adverse outcomes of pregnant women and puerpera,and their children,physiological hypercoagulability during pregnancy,pathogenesis and pathological characteristics of obstetric DIC,clinical manifestations and laboratory indicators of pregnant women and puerpera,as well as the latest research status of the evolution of diagnostic criteria and scoring system for obstetric DIC,in order to provide reference for clinical diagnosis and treatment of obstetric DIC patients.

表1 各国产科DIC评分系统比较
表2 日本Takao评分标准、CDSS产科DIC诊断评分系统中,产科DIC原发病及临床表现评分细则及标准
[1]
中华医学会血液学分会血栓与止血学组.产科弥散性血管内凝血临床诊断与治疗中国专家共识 [J].中华血液学杂志,2023,44(8):624-627.DOI:10.3760/cma.j.issn.0253-2727.2023.08.002.Thrombosis and Hemostasis Group,Chinese Society of Hematology,Chinese Medical Association.Consensus of Chinese experts on diagnosis and treatment of disseminated intravascular coagulation in obstetrics[J].Chin J Hematol,2023,44(8):624-627.DOI:10.3760/cma.j.issn.0253-2727.2023.08.002.
[2]
Lipkind HS,Zuckerwise LC,Turner EB,et al.Severe maternal morbidity d uring d elivery hospitalisation in a large international administrative database,2008-2013:a retrospective cohort[J].BJOG,2019,126(10):1223-1230.DOI:10.1111/1471-0528.15818.
[3]
Squizzato AA-O,Gallo A,Levi M,et al.Underlying disorders of disseminated intravascular coagulation:communication from the ISTH SSC subcommittees on disseminated intravascular coagulation and perioperative and critical care thrombosis and hemostasis[J].J Thromb Haemost,2020,18(9):2400-2407.DOI:10.1111/jth.14946.
[4]
Erez O,Othman M,Rabinovich A,et al.DICin pregnancypathophysiology,clinical characteristics,diagnostic scores,and treatments[J].J Blood Med,2022,13:21-44.DOI:10.2147/jbm.S273047.
[5]
Erez O,Mastrolia SA,Thachil J.Disseminated intravascular coagulation in pregnancy:insights in pathophysiology,diagnosis and management[J].Am J Obstet Gynecol,2015,213(4):452-463.DOI:10.1016/j.ajog.2015.03.054.
[6]
Ye Y,Vattai A,Zhang X,et al.Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases[J].Int J Mol Sci,2017,18(8):1651.DOI:10.3390/ijms18081651.
[7]
James AH,Rhee E,Thames B,et al.Characterization of antithrombin levels in pregnancy[J].Thromb Res,2014,134(3):648-651.DOI:10.1016/j.thromres.2014.07.025.
[8]
Kobayashi H,Matsubara S,Yoshimoto C,et al.Tissue factor pathway inhibitors as potential targets for understanding the pathophysiology of preeclampsia[J].Biomedicines,2023,11 (5):1237.DOI:10.3390/biomedicines11051237.
[9]
Levi M.Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism) [J].Thromb Res,2013,131(Suppl 1):S32-S34.DOI:10.1016/s0049-3848(13)70017-3.
[10]
Iba T,Connors JM,Nagaoka I,et al.Recent advances in the research and management of sepsis-associated DIC[J].Int J Hematol,2021,113(1):24-33.DOI:10.1007/s12185-020-03053-y.
[11]
Adelborg K,Larsen JB,Hvas AM.Disseminated intravascular coagulation:epidemiology,biomarkers,and management[J].Br J Haematol,2021,192(5):803-818.DOI:10.1111/bjh.17172.
[12]
Cunningham FG,Nelson DB.Disseminated intravascular coagulation syndromes in obstetrics[J].Obstet Gynecol,2015,126(5):999-1011.DOI:10.1097/AOG.000000 0000001110.
[13]
Pacheco LD,Saade G,Hankins GD,et al.Amniotic fluid embolism:diagnosis and management[J].Am J Obstet Gynecol,2016,215(2):B16-B24.DOI:10.1016/j.ajog.2016.03.012.
[14]
Erez O,Novack L,Beer-Weisel R,et al.DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score[J].PLoS One,2014,9(4):e93240.DOI:10.1371/journal.pone.0093240.
[15]
Masuda T,Shoko T,Deguchi Y.Clinical investigation of coagulation markers for early detection of sepsis-induced disseminated intravascular coagulation:a single-center,prospective observational study[J].Clin Appl Thromb Hemost,2018,24(7):1082-1087.DOI:10.1177/107 6029618762473.
[16]
Lee JH,Gu J,Kim HK.FactorⅦa-AT complex is an independent prognostic marker of disseminated intravascular coagulation[J].Ann Clin Lab Sci,2021,51(4):546-551.
[17]
Fang X,Fu W,Xu L,et al.Analysis of the diagnostic value of coagulation markers and coagulation function indices on the occurrence of DIC in sepsis and its prognosis[J].Allergol Immunopathol (Madr),2024,52(5):65-72.DOI:10.15586/aei.v52i5.1119.
[18]
Wada H,Matsumoto T,Hatada T.Diagnostic criteria and laboratory tests for disseminated intravascular coagulation[J].Expert Rev Hematol,2012,5(6):643-652.DOI:10.1586/ehm.12.57.
[19]
Amgalan A,Allen T,Othman M,et al.Systematic review of viscoelastic testing (TEG/ROTEM)in obstetrics and recommendations from the women's SSC of the ISTH[J].J Thromb Haemost,2020,18(8):1813-1838.DOI:10.1111/jth.14882.
[20]
Luo L,Wu Y,Niu T,et al.A multicenter,prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation[J].Thromb Res,2019,173:131-140.DOI:10.1016/j.thromres.2018.11.022.
[21]
Gando S,Iba T,Eguchi Y,et al.A multicenter,prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients:comparing current criteria[J].Crit Care Med,2006,34(3):625-631.DOI:10.1097/01.ccm.0000202209.42491.38.
[22]
Gando S,Wada H,Asakura H,et al.Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients[J].Clin Appl Thromb Hemost,2005,11(1):71-76.DOI:10.1177/107602 960501100108.
[23]
Hayakawa M,Gando S,Hoshino H.A prospective comparative study of three sets of criteria for disseminated intravascular coagulation:ISTH criteria vs Japanese criteria[J].Clin Appl Thromb Hemost,2007,13(1):65-72.DOI:10.1177/1076029606296405.
[24]
Rabinovich A,Abdul-Kadir R,Thachil J,et al.DIC in obstetrics:diagnostic score,highlights in management,and international registry-communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis[J].J Thromb Haemost,2019,17(9):1562-1566.DOI:10.1111/jth.14523.
[25]
Clark SL,Romero R,Dildy GA,et al.Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies[J].Am J Obstet Gynecol,2016,215(4):408-412.DOI:10.1016/j.ajog.2016.06.037.
[26]
Erez O.Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies[J].Am J Obstet Gynecol,2017,217(2):228-229.DOI:10.1016/j.ajog.2017.04.009.
[27]
Kobayashi T.Obstetrical disseminated intravascular coagulation score[J].J Obstet Gynaecol Res,2014,40(6):1500-1506.DOI:10.1111/jog.12426.
[28]
Kobayashi T,Terao T,Maki M,et al.Diagnosis and management of acute obstetrical DIC[J].Semin Thromb Hemost,2001,27 (2):161-167.DOI:10.1055/s-2001-14076.
[1] 李霞林, 贺芳. 产后出血风险评估和早期预警系统[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 498-503.
[2] 曾凡英, 阮洁, 刘兴会, 何国琳. 新生育形势下的围产医学研究现状及孕期保健中的应对策略[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 519-524.
[3] 李小飞, 刘洪莉, 石丘玲, 田静, 李莉, 漆洪波, 罗欣. 自然分娩产妇低强度聚焦超声子宫复旧治疗防治产后出血的前瞻性随机对照研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 534-539.
[4] 姚金含, 王伟娜, 张玉泉. 妊娠相关深静脉血栓形成患者的预后研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 367-373.
[5] 花卉, 许晨莹, 刘金凤. 盆底肌训练时机对高龄初产妇产后盆底肌张力及性功能的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 284-291.
[6] 薛静, 孙雅楠, 朱丽丽, 李淑红. 妊娠期急性脂肪肝孕产妇诊疗及其妊娠结局[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 312-321.
[7] 梅娟, 陶旭炜. 弥散性血管内凝血为首发表现先天性肝内门体静脉分流新生儿2例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 322-330.
[8] 李鑫钊, 张廷涛, 朱峰, 刘金山, 刘大闯. 血纤维蛋白原、D-二聚体及碱性磷酸酶诊断前列腺癌骨转移的价值分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 459-463.
[9] 魏微阳, 杨浩, 周川鹏, 王奇, 黄红星, 黄亚强. 纤维蛋白原与白蛋白比值及其列线图模型对非肌层浸润性膀胱癌患者电切术后复发的预测价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 243-248.
[10] 伍细蓉, 徐立文, 陈亚琼. 基于LPR和FARI构建肝衰竭患者生存预后模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 675-681.
[11] 孙顗淼, 张颖. 糖尿病患者急性脑梗死取栓术后发生对比剂肾病的影响因素及预测模型建立[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 188-194.
[12] 孙文恺, 沈青, 杭丽, 张迎春. 纤维蛋白原与清蛋白比值、中性粒细胞与白蛋白比值、C反应蛋白与溃疡性结肠炎病情评估和预后的关系[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 426-431.
[13] 周庆, 杨旭. 甲胎蛋白、纤维蛋白原与前白蛋白比值、癌胚抗原、D-二聚体对结肠癌术后复发的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 301-305.
[14] 高静, 夏婷婷. 血清乳酸脱氢酶、中性粒细胞/淋巴细胞比值、血浆纤维蛋白原/前白蛋白比值对晚期结直肠癌患者姑息化疗效果与不良反应的评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 203-207.
[15] 朱丽慈, 郑剑兰, 刘士璇, 张文蕾, 胡群, 陈丽旋. 妊娠期子宫嵌顿一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 232-236.
阅读次数
全文
0
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 0


摘要
35
最新录用 在线预览 正式出版
0 0 35
  来源 本网站 其他网站
  次数 8 27
  比例 23% 77%